Chitosan-based delivery systems for mucosal vaccines

By Jabbal-Gill Inderjit   Watts Peter   Smith Alan  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1051-1067

Informa Healthcare

Access to resources Recommend Favorite

The performance of nanocarriers for transmucosal drug delivery

By Csaba Noémi   Garcia-Fuentes Marcos   Alonso María José  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 4, 2006-07 ,pp. : 463-478

Informa Healthcare

Access to resources Recommend Favorite

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

By Baudner B.C.   Giuliani M.M.   Verhoef J.C.   Rappuoli R.   Junginger H.E.   Giudice G.D.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3837-3844

Elsevier

Access to resources Recommend Favorite

Mucosal vaccine delivery: is M cell-targeted delivery effective in the mucosal lumen?

By Lo David D  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 2, 2013-02 ,pp. : 157-161

Informa Healthcare

Access to resources Recommend Favorite

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM 197 ) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

By McNeela E.A.   O'Connor D.   Jabbal-Gill I.   Illum L.   Davis S.S.   Pizza M.   Peppoloni S.   Rappuoli R.   Mills K.H.G.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1188-1198

Elsevier

Access to resources Recommend Favorite